Bringing Together Vector Engineers and Scientists to Accelerate Gene Therapy Development

The past five years have been a critical turning point for gene therapy. From the first approved oligonucleotide-based therapy to the success of CAR-T cell therapies, followed by the recent in-vivo gene therapies and the emerging gene editing strategies, these gene therapeutics are not only life-changing for patients with rare diseases, but are also laying the foundation for potential treatments of other unmet medical needs.

Given the highly dynamic and competitive nature of the gene therapy industry, scientists are facing a multitude of challenges as they move from bench to clinic. This event thus hopes to gather the knowledge and expertise of scientists in vector engineering, analytics, immunogenicity assessments, preclinical development and clinical translation, to help accelerate next generation gene therapy development.

Join Our Growing Community of Scientists & Engineers